<DOC>
	<DOCNO>NCT00943657</DOCNO>
	<brief_summary>The purpose study verify immunogenicity tolerance trivalent seasonal influenza vaccine strain composition accord World Heath Organization/European Union ( WHO/EU ) recommendation 2009/2010 season yearly license application .</brief_summary>
	<brief_title>Yearly Strain Variation Study , 2009/2010</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject 18 59 year age , inclusive , time screening ( subject age stratum A ) Subject 60 year age old , inclusive , time screening ( subject age stratum B ) Subject give write informed consent prior study entry Subject generally healthy , determine investigator 's clinical judgment collection medical history performance physical examination , investigator would hesitate provide routine influenza immunization subject course routine medical practice Subject agree keep daily record symptom duration study If female childbearing potential , subject present negative urine pregnancy test , agree employ adequate birth control measure duration study Subject willing able comply requirement protocol Subject history severe allergic reaction anaphylaxis Subject oral temperature &gt; = 37.5°C day vaccination study Subject rash dermatologic condition tattoo , may interfere injection site reaction rating Subject receive live vaccine within 4 week inactivate subunit vaccine within 2 week study entry Subject receive seasonal influenza vaccine within 6 month study entry Subject currently history significant neurological , cardiovascular , pulmonary ( include asthma ) , hepatic , metabolic , rheumatic , autoimmune , hematological renal disorder Subject inherit acquire immunodeficiency Subject disease currently undergoing form treatment undergoing form treatment within 30 day prior study entry expect influence immune response . Such treatment include , limited , systemic high dose inhale ( &gt; 800 µg/day beclomethasone dipropionate equivalent ) corticosteroid , radiation treatment immunosuppressive cytotoxic drug . Subject functional surgical asplenia Subject know suspect problem alcohol drug abuse Subject member team conduct study dependent relationship one study team member . Dependent relationship include close relative ( ie , child , partner/spouse , sibling , parent ) well employee investigator site personnel conduct study If female , subject pregnant lactating time study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>